Nucleic Acid Isolation and Purification: Global Strategic Business Report

Global Nucleic Acid Isolation and Purification Market to Reach $9.6 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Nucleic Acid Isolation and Purification estimated at US$6.1 Billion in the year 2020, is projected to reach a revised size of US$9.6 Billion by 2027, growing at a CAGR of 6.7% over the analysis period 2020-2027. Kits, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 7.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 10.1% CAGR

The Nucleic Acid Isolation and Purification market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2027 trailing a CAGR of 10% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.

Reagents Segment to Record 6.5% CAGR

In the global Reagents segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.8% CAGR through the analysis period.

Select Competitors (Total 18 Featured) -

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• GE Healthcare
• Illumina, Inc.
• Merck KgaA
• New England Biolabs, Inc.
• Promega Corporation
• Qiagen NV
• Roche Molecular Systems, Inc.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

What's New for 2022?

• Global competitiveness and key competitor percentage market shares
  
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year